Skip to content

Clinical trials

Phase 1/2 Carcinoma, Hepatocellular trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 1/2 Country / region: United Kingdom Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20121
20131
20141
20171
20183
20192
20212
20221
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting3
Terminated3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
Eisai Inc.2
Imperial College London2
Cancer Research UK1
Celgene1
Forma Therapeutics, Inc.1
Grey Wolf Therapeutics1
Hoffmann-La Roche1
Kymab Limited1
Medivir1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular17
Carcinoma, Non-Small-Cell Lung3
Melanoma3
Neoplasms3
Stomach Neoplasms3
Uterine Cervical Neoplasms3
Cholangiocarcinoma2
Colorectal Neoplasms2
Esophageal Neoplasms2
Glioblastoma2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.